130 related articles for article (PubMed ID: 33221475)
21. Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein.
Ashraf NS; Sutton JR; Yang Y; Ranxhi B; Libohova K; Shaw ED; Barget AJ; Todi SV; Paulson HL; Costa MDC
Neurobiol Dis; 2020 Apr; 137():104697. PubMed ID: 31783119
[TBL] [Abstract][Full Text] [Related]
22. Childhood-Onset Spinocerebellar Ataxia 3: Tongue Dystonia as an Early Manifestation.
Mitchell N; LaTouche GA; Nelson B; Figueroa KP; Walker RH; Sobering AK
Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31565539
[TBL] [Abstract][Full Text] [Related]
23. New Model for Estimation of the Age at Onset in Spinocerebellar Ataxia Type 3.
Peng L; Chen Z; Long Z; Liu M; Lei L; Wang C; Peng H; Shi Y; Peng Y; Deng Q; Wang S; Zou G; Wan L; Yuan H; He L; Xie Y; Tang Z; Wan N; Gong Y; Hou X; Shen L; Xia K; Li J; Chen C; Qiu R; Klockgether T; Tang B; Jiang H
Neurology; 2021 Jun; 96(23):e2885-e2895. PubMed ID: 33893204
[TBL] [Abstract][Full Text] [Related]
24. Association Between Body Mass Index and Disease Severity in Chinese Spinocerebellar Ataxia Type 3 Patients.
Yang JS; Chen PP; Lin MT; Qian MZ; Lin HX; Chen XP; Shang XJ; Wang DN; Chen YC; Jiang B; Chen YJ; Wang N; Chen WJ; Gan SR
Cerebellum; 2018 Aug; 17(4):494-498. PubMed ID: 29476441
[TBL] [Abstract][Full Text] [Related]
25. Planning Future Clinical Trials for Machado-Joseph Disease.
Saute JAM; Jardim LB
Adv Exp Med Biol; 2018; 1049():321-348. PubMed ID: 29427112
[TBL] [Abstract][Full Text] [Related]
26. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.
Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M
Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414
[TBL] [Abstract][Full Text] [Related]
27. Brain stem and cerebellum volumetric analysis of Machado Joseph disease patients.
Camargos ST; Marques W; Santos AC
Arq Neuropsiquiatr; 2011; 69(2B):292-6. PubMed ID: 21625753
[TBL] [Abstract][Full Text] [Related]
28. Comparison of spinocerebellar ataxia type 3 mouse models identifies early gain-of-function, cell-autonomous transcriptional changes in oligodendrocytes.
Ramani B; Panwar B; Moore LR; Wang B; Huang R; Guan Y; Paulson HL
Hum Mol Genet; 2017 Sep; 26(17):3362-3374. PubMed ID: 28854700
[TBL] [Abstract][Full Text] [Related]
29. Alteration of methylation status in the ATXN3 gene promoter region is linked to the SCA3/MJD.
Wang C; Peng H; Li J; Ding D; Chen Z; Long Z; Peng Y; Zhou X; Ye W; Li K; Xu Q; Ai S; Song C; Weng L; Qiu R; Xia K; Tang B; Jiang H
Neurobiol Aging; 2017 May; 53():192.e5-192.e10. PubMed ID: 28094059
[TBL] [Abstract][Full Text] [Related]
30. Homozygote of spinocerebellar Ataxia type 3 correlating with severe phenotype based on analyses of clinical features.
Shang XJ; Xu HL; Yang JS; Chen PP; Lin MT; Qian MZ; Lin HX; Chen XP; Chen YC; Jiang B; Chen YJ; Chen WJ; Wang N; Zhou ZM; Gan SR
J Neurol Sci; 2018 Jul; 390():111-114. PubMed ID: 29801869
[TBL] [Abstract][Full Text] [Related]
31. Inactivation of PNKP by mutant ATXN3 triggers apoptosis by activating the DNA damage-response pathway in SCA3.
Gao R; Liu Y; Silva-Fernandes A; Fang X; Paulucci-Holthauzen A; Chatterjee A; Zhang HL; Matsuura T; Choudhary S; Ashizawa T; Koeppen AH; Maciel P; Hazra TK; Sarkar PS
PLoS Genet; 2015 Jan; 11(1):e1004834. PubMed ID: 25590633
[TBL] [Abstract][Full Text] [Related]
32. Homozygous spinocerebellar ataxia type 3 in China: a case report.
Chen Y; Li D; Wei M; Zhou M; Zhang L; Yu J; Qiu M; Jin Y; Lu X
J Int Med Res; 2021 Jun; 49(6):3000605211021370. PubMed ID: 34167352
[TBL] [Abstract][Full Text] [Related]
33. Serum concentrations of NSE and S100B in spinocerebellar ataxia type 3/Machado-Joseph disease.
Zhou J; Lei L; Shi Y; Wang J; Jiang H; Shen L; Tang B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):504-10. PubMed ID: 21743141
[TBL] [Abstract][Full Text] [Related]
34. Autophagy Promoted the Degradation of Mutant ATXN3 in Neurally Differentiated Spinocerebellar Ataxia-3 Human Induced Pluripotent Stem Cells.
Ou Z; Luo M; Niu X; Chen Y; Xie Y; He W; Song B; Xian Y; Fan D; OuYang S; Sun X
Biomed Res Int; 2016; 2016():6701793. PubMed ID: 27847820
[TBL] [Abstract][Full Text] [Related]
35. Spinocerebellar ataxias types 1, 2 and 3: age adjusted clinical severity of disease at presentation correlates with size of CAG repeat lengths.
Netravathi M; Pal PK; Purushottam M; Thennarasu K; Mukherjee M; Jain S
J Neurol Sci; 2009 Feb; 277(1-2):83-6. PubMed ID: 19049837
[TBL] [Abstract][Full Text] [Related]
36. In vivo assessment of riluzole as a potential therapeutic drug for spinocerebellar ataxia type 3.
Schmidt J; Schmidt T; Golla M; Lehmann L; Weber JJ; Hübener-Schmid J; Riess O
J Neurochem; 2016 Jul; 138(1):150-62. PubMed ID: 26990650
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic variance in monozygotic twins with SCA3.
Zhao H; Yang L; Dong Y; Wu ZY
Mol Genet Genomic Med; 2020 Oct; 8(10):e1438. PubMed ID: 32729243
[TBL] [Abstract][Full Text] [Related]
38. Deficiency in classical nonhomologous end-joining-mediated repair of transcribed genes is linked to SCA3 pathogenesis.
Chakraborty A; Tapryal N; Venkova T; Mitra J; Vasquez V; Sarker AH; Duarte-Silva S; Huai W; Ashizawa T; Ghosh G; Maciel P; Sarkar PS; Hegde ML; Chen X; Hazra TK
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):8154-8165. PubMed ID: 32205441
[TBL] [Abstract][Full Text] [Related]
39. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
[TBL] [Abstract][Full Text] [Related]
40. Generation of an induced pluripotent stem cell line from a patient with spinocerebellar ataxia type 3 (SCA3): HIHCNi002-A.
Hayer SN; Schelling Y; Huebener-Schmid J; Weber JJ; Hauser S; Schöls L
Stem Cell Res; 2018 Jul; 30():171-174. PubMed ID: 29936336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
